Literature DB >> 23171316

Associations of the IL-1F7 gene polymorphisms with rheumatoid arthritis in Chinese Han population.

B Pei1, S Xu, T Liu, F Pan, J Xu, C Ding.   

Abstract

Our aim was to investigate whether genetic polymorphism of IL-1F7 (rs3811047) was involved in the susceptibility to rheumatoid arthritis (RA) in Chinese Han population. Single nucleotide polymorphism (SNP) of IL-1F7 gene (rs3811047) was analyzed in 184 unrelated Chinese Han patients with RA and 184 healthy controls by ligase detection reaction based on high temperature ligase detection reactions polymerase chain reaction (LDR-PCR). There were no statistically significant differences in the genetic polymorphism (genotypes and allele frequencies) of IL-1F7 (rs3811047) in the patients with RA compared with control. Although all of the clinical and laboratory measures were similar to each other among patients with different genotypes, RA patients carrying AA or AG genotypes had lower swollen joint count, swollen joint index, rest pain and health assessment questionnaire (HAQ) score than that in patients having GG genotype (P < 0.05). These findings show that no evidence for the involvement of a pro-inflammatory polymorphism in the IL-1F7 in the susceptibility to RA in China. Patients carrying A allele had less severe disease activity than those not carrying this allele, suggesting that the A allele of IL-1F7 gene (rs3811047) may have a protective effect on RA.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23171316     DOI: 10.1111/iji.12007

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  17 in total

1.  Interleukin-37 gene variants segregated anciently coexist during hominid evolution.

Authors:  Bin Kang; Shimeng Cheng; Jinbiao Peng; Jingjing Yan; Shuye Zhang
Journal:  Eur J Hum Genet       Date:  2015-01-28       Impact factor: 4.246

2.  The variant interleukin 1f7 rs3811047 G>A was associated with a decreased risk of gastric cardiac adenocarcinoma in a Chinese Han population.

Authors:  Xu Wang; Jun Yin; Liang Zheng; Liming Wang; Yijun Shi; Weifeng Tang; Guowen Ding; Chao Liu; Ruiping Liu; Suocheng Chen; Haiyong Gu
Journal:  Tumour Biol       Date:  2013-12-21

Review 3.  IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance.

Authors:  Dov B Ballak; Rinke Stienstra; Cees J Tack; Charles A Dinarello; Janna A van Diepen
Journal:  Cytokine       Date:  2015-07-17       Impact factor: 3.861

Review 4.  Biology of interleukin-37 and its role in autoimmune diseases (Review).

Authors:  Huiqiong Zeng; Kaixia Zhou; Zhizhong Ye
Journal:  Exp Ther Med       Date:  2022-06-07       Impact factor: 2.751

5.  Common genetic heterogeneity of human interleukin-37 leads to functional variance.

Authors:  Jingjing Yan; Yuling Zhang; Shimeng Cheng; Bin Kang; Jinbiao Peng; Xiaodan Zhang; Meichun Yuan; Wenqi Chu; Wen Zhang; Jiayin Shen; Shuye Zhang
Journal:  Cell Mol Immunol       Date:  2016-09-26       Impact factor: 11.530

Review 6.  Suppression of innate inflammation and immunity by interleukin-37.

Authors:  Charles A Dinarello; Claudia Nold-Petry; Marcel Nold; Mayumi Fujita; Suzhao Li; Soohyun Kim; Philip Bufler
Journal:  Eur J Immunol       Date:  2016-05       Impact factor: 5.532

7.  The evaluation of plasma and leukocytic IL-37 expression in early inflammation in patients with acute ST-segment elevation myocardial infarction after PCI.

Authors:  Xin Wang; Xiangna Cai; Lan Chen; Duanmin Xu; Jilin Li
Journal:  Mediators Inflamm       Date:  2015-04-16       Impact factor: 4.711

8.  Genetic analysis of innate immunity in Behcet's disease identifies an association with IL-37 and IL-18RAP.

Authors:  Handan Tan; Bolin Deng; Hongsong Yu; Yi Yang; Lin Ding; Qi Zhang; Jieying Qin; Aize Kijlstra; Rui Chen; Peizeng Yang
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

9.  IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation.

Authors:  Haipeng Liu; Ruijuan Zheng; Peng Wang; Hua Yang; Xin He; Qun Ji; Wenjuan Bai; Hao Chen; Jianxia Chen; Wenxia Peng; Siyu Liu; Zhonghua Liu; Baoxue Ge
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

10.  Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.

Authors:  Lin Lin; Jiayi Wang; Dongjuan Liu; Sai Liu; Hao Xu; Ning Ji; Min Zhou; Xin Zeng; Dunfang Zhang; Jing Li; Qianming Chen
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.